Gregory A Denomme

Title: Gregory A Denomme: Innovator in Blood Group Genotyping

Introduction

Gregory A Denomme is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of blood group genotyping, particularly in the context of transfusion medicine. His work focuses on improving the safety and efficiency of blood transfusions through innovative methodologies.

Latest Patents

Denomme holds a patent for a method that allows for the simultaneous determination of blood group and platelet antigen genotypes. This invention addresses the critical need for antigen-matched blood to prevent adverse transfusion reactions. The patent details a multiplex PCR-oligonucleotide extension assay utilizing the GenomeLab SNPStream platform. This assay is designed to genotype blood for various blood group antigen-associated single nucleotide polymorphisms (SNPs), including RhD, RhC/c, RhE/e, S/s, K/k, Kp, Fya/b, FY0, Jk, Di, and HPA-1a/b. He has 1 patent to his name.

Career Highlights

Gregory A Denomme is affiliated with Canadian Blood Services, where he applies his expertise in blood group genotyping. His work is instrumental in enhancing the safety protocols surrounding blood transfusions. By developing methods that utilize SNPs for blood typing, he has contributed to more reliable and efficient blood screening processes.

Collaborations

Due to space constraints, the collaborations section has been omitted.

Conclusion

Gregory A Denomme's innovative approach to blood group genotyping exemplifies the importance of advancements in medical technology. His contributions significantly enhance the safety of blood transfusions, ultimately benefiting patients in need.